Local anesthetic
A local anesthetic (LA) is a medication that causes absence of all sensation (including pain) in a specific body part without loss of consciousness, providing local anesthesia, as opposed to a general anesthetic, which eliminates all…
≈ 8 min read
Local anesthetic. encyclopegia.org, snapshot enwiki-001373721679. /a/local-anesthetic
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
A local anesthetic (LA) is a medication that causes absence of all sensation (including pain) in a specific body part without loss of consciousness, providing local anesthesia, as opposed to a general anesthetic, which eliminates all sensation in the entire body and causes unconsciousness. Local anesthetics are most commonly used to eliminate pain during or after surgery.
During local anesthesia, pain and temperature are the first senses to disappear, while pressure and motor function are the last to go.When it is used on specific nerve pathways (local anesthetic nerve block), paralysis (loss of muscle function) also can be induced.
Classification
LAs are of 2 types: Clinical LAs: amino amide LAs amino ester LAs Synthetic LAs Cocaine derivatives Synthetic cocaine-derived LAs differ from cocaine because they have a much lower abuse potential and do not cause hypertension vasoconstriction (with few exceptions). The suffix "-caine" at the ends of these medication names is derived from the word "cocaine", because cocaine was formerly used as a local anesthetic.
Acute pain
Even though acute pain can be managed using analgesics, conduction anesthesia may be preferable because of superior pain control and fewer side effects. For purposes of pain therapy, LA drugs are often given by repeated injection or continuous infusion through a catheter. LA drugs are also often combined with other agents such as opioids for synergistic analgesic action.
Low doses of LA drugs can be sufficient so that muscle weakness does not occur and patients may be mobilized. Some typical uses of conduction anesthesia for acute pain are:
Chronic pain
Chronic pain is a complex and often serious condition that requires diagnosis and treatment by an expert in pain medicine. LAs can be applied repeatedly or continuously for prolonged periods to relieve chronic pain, usually in combination with medication such as opioids, NSAIDs, and anticonvulsants.
Though it can be easily performed, repeated local anesthetic blocks in chronic pain conditions are not recommended as there is no evidence of long-term benefits.
Localized side effects
Edema of tongue, pharynx and larynx may develop as a side effect of local anesthesia. This could be caused by a variety of reasons including trauma during injection, infection, an allergic reaction, haematoma or injection of irritating solutions such as cold-sterilization solutions. Usually there is tissue swelling at the point of injection.
This is due to puncturing of the vein which allows the blood to flow into loose tissues in the surrounding area. Blanching of the tissues in the area where the local anesthetic is deposited is also common. This gives the area a white appearance as the blood flow is prevented due to vasoconstriction of arteries in the area.
The vasoconstriction stimulus gradually wears off and subsequently the tissue returns to normal in less than two hours. The side effects of inferior alveolar nerve block include feeling tense, clenching of the fists and moaning. The duration of soft tissue anesthesia is longer than pulpal anesthesia and is often associated with difficulty eating, drinking and speaking.
Risks
The risk of temporary or permanent nerve damage varies between different locations and types of nerve blocks. There is risk of accidental damage to local blood vessels during injection of the local anesthetic solution. This is referred to as haematoma and could result in pain, trismus, swelling and/or discoloration of the region.
The density of tissues surrounding the injured vessels is an important factor for hematoma. There is greatest chance of this occurring in a posterior superior alveolar nerve block or in a pterygomandibular block. Giving local anesthesia to patients with liver disease can have significant consequences.
Thorough evaluation of the disease should be carried out to assess potential risk to the patient as in significant liver dysfunction, the half-life of amide local anesthetic agents may be drastically increased thus increasing the risk of overdose. Local anesthetics and vasoconstrictors may be administered to pregnant patients however it is very important to be extra cautious when giving a pregnant patient any type of drug.
Lidocaine can be safely used but bupivacaine and mepivacaine should be avoided. Consultation with the obstetrician is vital before administering any type of local anesthetic to a pregnant patient.
Recovery
Permanent nerve damage after a peripheral nerve block is rare. Symptoms are likely to resolve within a few weeks. The vast majority of those affected (92–97%) recover within four to six weeks; 99% of these people have recovered within a year.
An estimated one in 5,000 to 30,000 nerve blocks results in some degree of permanent persistent nerve damage. Symptoms may continue to improve for up to 18 months following injury.
Potential side effects
General systemic adverse effects are due to the pharmacological effects of the anesthetic agents used. The conduction of electric impulses follows a similar mechanism in peripheral nerves, the central nervous system, and the heart. The effects of local anesthetics are, therefore, not specific for the signal conduction in peripheral nerves.
Side effects on the central nervous system and the heart may be severe and potentially fatal. However, toxicity usually occurs only at plasma levels which are rarely reached if proper anesthetic techniques are adhered to.
High plasma levels might arise, for example, when doses intended for epidural or intrasupport tissue administration are accidentally delivered as intravascular injection.
Treatment of overdose: "Lipid rescue"
Lipid emulsion therapy or lipid rescue is a method of toxicity treatment that was invented by Dr. Guy Weinberg in 1998, and was not widely used until after the first published successful rescue in 20061. Evidence indicates Intralipid, a commonly available intravenous lipid emulsion, can be effective in treating severe cardiotoxicity secondary to local anesthetic overdose, including human case reports.
However, the evidence at this point is still limited. Though most case reports to date have recorded most common use of Intralipid, other emulsions, such as Liposyn and Medialipid, have also been shown effective. Ample supporting animal evidence and human case reports show successful use of lipid rescue in this way.
In the UK, efforts have been made to publicize lipid rescue more widely. In 2010, lipid rescue had been officially promoted as a treatment of local anesthetic toxicity by the Association of Anaesthetists of Great Britain and Ireland. One published case has been reported of successful treatment of refractory cardiac arrest in bupropion and lamotrigine overdose using lipid emulsion.
The design of a 'homemade' lipid rescue kit consisting of a standard lipid injection, IV tubing, syringes, and needles has been described. Although lipid rescue mechanism of action is not completely understood, the added lipid in the blood stream may act as a sink, allowing for the removal of lipophilic toxins from affected tissues.
This theory is compatible with two studies on lipid rescue for clomipramine toxicity in rabbits and with a clinical report on the use of lipid rescue in veterinary medicine to treat a puppy with moxidectin toxicosis.
Sensitivity of nerve fibers to local anesthetics
For most patients, administration of local anesthetics causes the sensation of pain to be lost first, followed by temperature, touch, deep pressure, and finally motor function. The sensitivity of nerve fibers to blockade depends on a combination of diameter and myelination. Their different sensitivities to LA blockade is termed differential blockade.
Myelinated fibers are more sensitive to blockade as they are interrupted by nodes of Ranvier, thus interruption of only consecutive nodes of Ranvier will prevent action potential propagation. In turn, in unmyelinated nerves, an entire length needs to be blocked.
Regarding diameter, the generally accepted principle is that susceptibility to local anesthesia depends inversely on fiber diameter. In general, autonomic fibers Type B fibers, small unmyelinated type C (pain sensation), and small myelinated Aδ fibers(pain and temperature sensations) are blocked before the larger myelinated Aγ, Aβ, and Aα fibers (mediating postural, touch, pressure, and motor information).
Ester group
Benzocaine Chloroprocaine Cocaine Cyclomethycaine Dimethocaine (Larocaine) Oxybuprocaine Piperocaine Propoxycaine Procaine (Novocaine) Proparacaine Tetracaine (Amethocaine)
Amide group
Articaine Bupivacaine Cinchocaine (Dibucaine) Etidocaine Levobupivacaine Lidocaine (Lignocaine) Mepivacaine Prilocaine Ropivacaine Trimecaine
Naturally derived
Saxitoxin Neosaxitoxin Tetrodotoxin Menthol Eugenol Cocaine Spilanthol Most naturally occurring local anesthetics with the exceptions of menthol, eugenol and cocaine are neurotoxins, and have the suffix -toxin in their names. Cocaine binds the intracellular side of the channels while saxitoxin, neosaxitoxin and tetrodotoxin bind to the extracellular side of sodium channels.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1373721679 under CC BY-SA 4.0; modifications have been made.
References
- ↩Wikipedia “Local anesthetic” publication date (×1) · confidence 0.95 revision URL